您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股招股说明书]:道明银行美股招股说明书(2026-02-25版) - 发现报告

道明银行美股招股说明书(2026-02-25版)

2026-02-25美股招股说明书G***
AI智能总结
查看更多
道明银行美股招股说明书(2026-02-25版)

Pricing Supplement datedFebruary 25, 2026 to theProduct Supplement MLN-ES-ETF-1 dated February 26, 2025,and Prospectus dated February 26, 2025 The Toronto-Dominion Bank $874,000Capped Notes Linked to the shares of the iShares®MSCI Emerging Markets ETFDue February 27, 2031 The Toronto-Dominion Bank (“TD” or “we”) has offered the Capped Notes (the “Notes”) linked to the shares of the iShares®MSCIEmerging Markets ETF (the “Reference Asset”). We also refer to an exchange-traded fund as an “ETF”. The Notes provide unleveraged participation in the positive return of the Reference Asset if the value of the Reference Asset increasesfrom the Initial Value to the Final Value, subject to the Maximum Redemption Amount of $1,577.00 per Note. Investors will receive theirPrincipal Amount at maturity if the Final Value isequal to or less thanthe Initial Value.Payment on the Notes is subject to our creditrisk. The Payment at Maturity will be greater than the Principal Amount only if the Final Value is greater than the Initial Value.Payment on the Notes is subject to our credit risk.The Notes are unsecured and are not savings accounts or insured deposits of a bank. The Notes are not insured or guaranteed by the Canada Deposit Insurance Corporation, the U.S. Federal Deposit Insurance Corporation or any other governmental agency orinstrumentality of Canada or the United States. The Notes will not be listed or displayed on any securities exchange or electroniccommunications network. The Notes have complex features and investing in the Notes involves a number of risks. See “Additional Risk Factors”beginning on page P-6 of this pricing supplement, “Additional Risk Factors Specific to the Notes” beginning on page PS-7 ofthe product supplement MLN-ES-ETF-1 dated February 26, 2025 (the “product supplement”) and “Risk Factors” on page 1 ofthe prospectus dated February 26, 2025 (the “prospectus”). Neitherthe Securities and Exchange Commission(the“SEC”)nor any state securities commission has approved ordisapproved of these Notes or determined that this pricing supplement, the product supplement or the prospectus is truthfulor complete. Any representation to the contrary is a criminal offense. We will deliver the Notes in book-entry only form through the facilities of The Depository Trust Company on the Issue Date, againstpayment in immediately available funds. The estimated value of your Notes at the time the terms of your Notes were set on the Pricing Date was $974.50 per Note, asdiscussed further under “Additional Risk Factors — Risks Relating to Estimated Value and Liquidity” beginning on page P-8 and“Additional Information Regarding the Estimated Value of the Notes” on page P-22 of this pricing supplement. The estimated value isless than the public offering price of the Notes. 1Certain dealers who purchase the Notes for sale to certain fee-based advisory accounts may have agreed to forgo some or all of their sellingconcessions, fees or commissions. The public offering price for investors purchasing the Notes in these accounts may have been as low as $992.50(99.25%) per Note.2 TD Securities (USA) LLC (“TDS”) will receive a commission of $7.50 (0.75%) per Note and will use all of that commission to allow selling concessionsto other dealers in connection with the distribution of the Notes. Such other dealers may resell the Notes to other securities dealers at the PrincipalAmount less a concession not in excess of $7.50 per Note. TD will reimburse TDS for certain expenses in connection with its role in the offer and saleof the Notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the Notes. See “Supplemental Plan of Distribution (Conflictsof Interest)” herein. The public offering price, underwriting discount and proceeds to TD listed above relate to the Notes we issue initially. We may decide to sell additionalNotes after the date of this pricing supplement, at public offering prices and with underwriting discounts and proceeds to TD that differ from the amountsset forth above. Any return on your investment in the Notes will depend in part on the public offering price you pay for such Notes. Capped Notes Linked to the shares of the iShares®MSCI EmergingMarkets ETFDue February 27, 2031 Summary The information in this “Summary” section is qualified by the more detailed information set forth in this pricing supplement, the productsupplement and the prospectus. Additional Terms of Your Notes You should read this pricing supplement together with the prospectus, as supplemented by the product supplement MLN-ES-ETF-1 (the“product supplement”), relating to our Senior Debt Securities, Series H, of which these Notes are a part. Capitalized terms used but notdefined in this pricing supplement will have the meanings given to them in the product supplement. In the event of any conflict thefollowing hierarchy will govern: first, this pricing supplement; second, the product supplement; and last, the p